These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 27440960)

  • 41. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
    Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
    Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antifungal therapy in infants and children with proven, probable or suspected invasive fungal infections.
    Blyth CC; Hale K; Palasanthiran P; O'Brien T; Bennett MH
    Cochrane Database Syst Rev; 2010 Feb; 2010(2):CD006343. PubMed ID: 20166083
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Outcomes of cryptococcosis in renal transplant recipients in a less-resourced health care system.
    Ponzio V; Camargo LF; Medina-Pestana J; Perfect JR; Colombo AL
    Transpl Infect Dis; 2018 Aug; 20(4):e12910. PubMed ID: 29677399
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance.
    Nguyen MH; Peacock JE; Morris AJ; Tanner DC; Nguyen ML; Snydman DR; Wagener MM; Rinaldi MG; Yu VL
    Am J Med; 1996 Jun; 100(6):617-23. PubMed ID: 8678081
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Successful treatment of pulmonary blastomycosis with continuously infused amphotericin B deoxycholate after failure with liposomal amphotericin B.
    Ariano RE; Mitchelmore BR; Lagacé-Wiens PR; Zelenitsky SA
    Ann Pharmacother; 2013 Jun; 47(6):e26. PubMed ID: 23673538
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A randomized comparison of fluconazole with amphotericin B as empiric anti-fungal agents in cancer patients with prolonged fever and neutropenia.
    Malik IA; Moid I; Aziz Z; Khan S; Suleman M
    Am J Med; 1998 Dec; 105(6):478-83. PubMed ID: 9870832
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome.
    Tumbarello M; Sanguinetti M; Trecarichi EM; La Sorda M; Rossi M; de Carolis E; de Gaetano Donati K; Fadda G; Cauda R; Posteraro B
    J Antimicrob Chemother; 2008 Dec; 62(6):1379-85. PubMed ID: 18782778
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biguanides enhance antifungal activity against Candida glabrata.
    Xu S; Feliu M; Lord AK; Lukason DP; Negoro PE; Khan NS; Dagher Z; Feldman MB; Reedy JL; Steiger SN; Tam JM; Soukas AA; Sykes DB; Mansour MK
    Virulence; 2018; 9(1):1150-1162. PubMed ID: 29962263
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The activity of echinocandins, amphotericin B and voriconazole against fluconazole-susceptible and fluconazole-resistant Brazilian Candida glabrata isolates.
    Mario DA; Denardi LB; Bandeira LA; Antunes MS; Santurio JM; Severo LC; Alves SH
    Mem Inst Oswaldo Cruz; 2012 May; 107(3):433-6. PubMed ID: 22510843
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antifungals and renal safety--getting the balance right.
    Saliba F
    Int J Antimicrob Agents; 2006 Jun; 27 Suppl 1():21-4. PubMed ID: 16704922
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The trend of susceptibilities to amphotericin B and fluconazole of Candida species from 1999 to 2002 in Taiwan.
    Yang YL; Li SY; Cheng HH; Lo HJ;
    BMC Infect Dis; 2005 Nov; 5():99. PubMed ID: 16266438
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antifungal prophylaxis with low-dose fluconazole during bone marrow transplantation. The Bone Marrow Transplantation Team.
    Alangaden G; Chandrasekar PH; Bailey E; Khaliq Y
    Bone Marrow Transplant; 1994 Dec; 14(6):919-24. PubMed ID: 7711669
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antifungal susceptibility of Candida isolates at one institution.
    Katsuragi S; Sata M; Kobayashi Y; Miyoshi T; Yamashita Y; Neki R; Horiuchi C; Yamanaka K; Kamiya C; Iwanaga N; Tanaka H; Ikeda T; Yoshimatsu J
    Med Mycol J; 2014; 55(1):E1-7. PubMed ID: 24682093
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Toxicity and efficacy of conventional amphotericin B deoxycholate versus escalating doses of amphotericin B deoxycholate---fat emulsion in HIV-infected patients with oral candidosis.
    Chavanet P; Clement C; Duong M; Buisson M; D'Athis P; Dumas M; Bonnin A; Portier H
    Clin Microbiol Infect; 1997 Aug; 3(4):455-461. PubMed ID: 11864156
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Amphotericin B colloidal dispersion.
    Patel R
    Expert Opin Pharmacother; 2000 Mar; 1(3):475-88. PubMed ID: 11249532
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of high-dose liposomal amphotericin B: efficacy and tolerance.
    Garbino J; Adam A
    Acta Biomed; 2006; 77 Suppl 4():19-22. PubMed ID: 17370566
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Safety of a weekly high dose of liposomal amphotericin B for prophylaxis of invasive fungal infection in immunocompromised patients: PROPHYSOME Study.
    Cordonnier C; Mohty M; Faucher C; Pautas C; Robin M; Vey N; Monchecourt F; Mahi L; Ribaud P
    Int J Antimicrob Agents; 2008 Feb; 31(2):135-41. PubMed ID: 18162375
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Candida glabrata liver abscess and fungemia complicating severe calculus cholecystitis in an immunocompetent nondiabetic host.
    Lima R; Shams W; Kalra S; Borthwick T
    South Med J; 2010 Mar; 103(3):245-7. PubMed ID: 20134390
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anidulafungin: a new echinocandin with a novel profile.
    Vazquez JA
    Clin Ther; 2005 Jun; 27(6):657-73. PubMed ID: 16117974
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Update from a 12-Year Nationwide Fungemia Surveillance: Increasing Intrinsic and Acquired Resistance Causes Concern.
    Astvad KMT; Johansen HK; Røder BL; Rosenvinge FS; Knudsen JD; Lemming L; Schønheyder HC; Hare RK; Kristensen L; Nielsen L; Gertsen JB; Dzajic E; Pedersen M; Østergård C; Olesen B; Søndergaard TS; Arendrup MC
    J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29212705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.